Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis
- PMID: 15077298
- DOI: 10.1002/art.20134
Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis
Abstract
Objective: The stress protein and endoplasmic reticulum chaperone, immunoglobulin binding protein (BiP), is an autoantigen in rheumatoid arthritis (RA). Stress proteins, however, may have extracellular functions, mediated via cell surface receptors, that may include immunomodulatory functions. We sought to determine whether cell-free BiP is present in the synovial fluid (SF) of patients with RA and to further investigate the possible extracellular antiinflammatory and immunomodulatory properties of BiP in peripheral blood mononuclear cells (PBMCs) in vitro.
Methods: The presence of BiP in SF was established by Western blotting. PBMCs were stimulated with exogenous recombinant human BiP, and cytokine production and cell proliferation were measured in the presence and absence of cell signaling inhibitors or neutralizing anti-interleukin-10 (anti-IL-10) monoclonal antibody. Cytokine levels were quantified by enzyme-linked immunosorbent assay, cell proliferation by tritiated thymidine uptake, and cell surface molecule expression by flow cytometry.
Results: PBMCs responded to BiP with secretion of an antiinflammatory profile of cytokines. Although BiP stimulated the early production of tumor necrosis factor alpha (TNF alpha), the major cytokine induced was IL-10. Soluble TNF receptor II and IL-1 receptor antagonist secretion was also increased. Addition of SB203580, the MAPK p38 pathway inhibitor, partially inhibited the production of IL-10 and TNF alpha, whereas they were unaffected by the MAPK ERK-1/2 inhibitor PD98059. BiP also inhibited the recall antigen response by PBMCs to tuberculin purified protein derivative. Further investigation showed that incubation of monocytes in the presence of either BiP or IL-10 down-regulated CD86 and HLA-DR expression. The effect observed with IL-10 was transient compared with the long-lasting reduction induced by BiP.
Conclusion: Extracellular BiP may stimulate immunomodulatory and antiinflammatory pathways, which are only partly due to the production of IL-10. These properties may be of relevance for the treatment of diseases such as RA.
Similar articles
-
Immunoglobulin heavy-chain-binding protein (BiP): a stress protein that has the potential to be a novel therapy for rheumatoid arthritis.Biochem Soc Trans. 2014 Dec;42(6):1752-5. doi: 10.1042/BST20140230. Biochem Soc Trans. 2014. PMID: 25399601 Review.
-
Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.Arthritis Rheum. 2004 May;50(5):1457-67. doi: 10.1002/art.20219. Arthritis Rheum. 2004. PMID: 15146415
-
Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.Arthritis Rheum. 2004 Feb;50(2):432-43. doi: 10.1002/art.20064. Arthritis Rheum. 2004. PMID: 14872485
-
The mode of action of cytokine inhibitors.J Rheumatol Suppl. 2002 Sep;65:16-21. J Rheumatol Suppl. 2002. PMID: 12236617 Review.
-
Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10.J Immunol. 1999 Nov 15;163(10):5599-607. J Immunol. 1999. PMID: 10553089
Cited by
-
The Biologic IRL201805 Alters Immune Tolerance Leading to Prolonged Pharmacodynamics and Efficacy in Rheumatoid Arthritis Patients.Int J Mol Sci. 2024 Apr 16;25(8):4394. doi: 10.3390/ijms25084394. Int J Mol Sci. 2024. PMID: 38673979 Free PMC article. Clinical Trial.
-
Damage-mediated macrophage polarization in sterile inflammation.Front Immunol. 2023 Jul 3;14:1169560. doi: 10.3389/fimmu.2023.1169560. eCollection 2023. Front Immunol. 2023. PMID: 37465676 Free PMC article. Review.
-
The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases.J Cell Mol Med. 2023 Feb;27(3):322-339. doi: 10.1111/jcmm.17669. Epub 2023 Jan 18. J Cell Mol Med. 2023. PMID: 36651415 Free PMC article. Review.
-
Resolution Potential of Necrotic Cell Death Pathways.Int J Mol Sci. 2022 Dec 20;24(1):16. doi: 10.3390/ijms24010016. Int J Mol Sci. 2022. PMID: 36613458 Free PMC article. Review.
-
ER-stress-induced secretion of circulating glucose-regulated protein 78kDa (GRP78) ameliorates pulmonary artery smooth muscle cell remodelling.Cell Stress Chaperones. 2022 Sep;27(5):561-572. doi: 10.1007/s12192-022-01292-y. Epub 2022 Aug 27. Cell Stress Chaperones. 2022. PMID: 36029373 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous